Location History:
- Bagsvord, DK (2006)
- Lyngby, DK (2005 - 2007)
- Bagsvaerd, DK (2012)
Company Filing History:
Years Active: 2005-2012
Title: Rafael Taboryski: Innovator in Microfluidics and Electrophysiology
Introduction
Rafael Taboryski is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the fields of microfluidics and electrophysiology, holding a total of 4 patents. His work focuses on advancing technologies that enhance the understanding and analysis of cell membranes.
Latest Patents
Among his latest patents is the "Capillary Stop," which describes a microfluidics system featuring a channel with an inlet and an outlet. This system includes a first membrane positioned between the inlet and outlet, equipped with an aperture that has a radius ranging from 0.1 to 50 μm. This design allows fluid to move efficiently along the channel. Another significant patent is for a "Substrate and Method for Measuring the Electro-Physiological Properties of Cell Membranes." This invention involves a substantially planar substrate used in patch clamp analysis, which includes a glycocalyx and an aperture designed to form a gigaseal upon contact with the cell membrane. The patent also outlines a method for creating such a substrate and analyzing the electrophysiological properties of cell membranes.
Career Highlights
Rafael Taboryski is currently associated with Sophion Bioscience A/S, a company that specializes in innovative solutions for electrophysiology. His work at Sophion has allowed him to push the boundaries of research in this critical area of science.
Collaborations
Throughout his career, Rafael has collaborated with notable colleagues, including Jonatan Kutchinsky and Morten Bech. These collaborations have further enriched his research and contributed to the advancements in the technologies he has developed.
Conclusion
Rafael Taboryski stands out as an influential inventor in the realms of microfluidics and electrophysiology. His patents and work at Sophion Bioscience A/S reflect his commitment to innovation and scientific advancement.